Impact of Soylent Consumption on Human Microbiome Composition
1 other identifier
interventional
14
0 countries
N/A
Brief Summary
Soylent 2.0 is a popular meal replacement drink that is used to supplement or replace one's regular diet. Soylent is designed to fully fulfill one's nutritional needs, but its impact on the human microbiome remains unknown. This study aims to track the composition of participants' gut microbiomes before, during, and after Soylent consumption to more holistically understand its impact on microbiome health. We predict that a short term Soylent-based diet will induce observable and reversible changes to participants' gut microbiomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 16, 2016
CompletedFirst Submitted
Initial submission to the registry
June 27, 2017
CompletedFirst Posted
Study publicly available on registry
June 29, 2017
CompletedJune 29, 2017
June 1, 2017
1 month
June 27, 2017
June 27, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes to gut microbiome composition as a result of an interventional Soylent diet
Days 3-6 of the study
Study Arms (2)
Regular Diet Arm
NO INTERVENTIONMaintains a regular diet for the duration of the study.
Soylent Diet Arm
EXPERIMENTALReceives a Soylent dietary intervention on days 3-6 of the study.
Interventions
A diet of five servings of Soylent 2.0 liquid meal-replacement drink per day and water as needed.
Eligibility Criteria
You may qualify if:
- The subject population will consist of undergraduate UC Berkeley students.
You may not qualify if:
- Dietary allergies or sensitivities to Soylent 2.0 ingredients
- Vulnerable individuals as defined by Committee for Protection of Human Subjects guidelines
- Individuals with health issues
- Individuals who take antibiotics, probiotics, alcohol, or supplements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Adam P Arkin, PhD
Professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 27, 2017
First Posted
June 29, 2017
Study Start
October 10, 2016
Primary Completion
November 16, 2016
Study Completion
November 16, 2016
Last Updated
June 29, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will share
Bacterial DNA sequencing data from collected fecal samples will be shared in a public repository. Sample labels will be deidentified.